Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-16-762290
Filing Date
2016-11-08
Accepted
2016-11-08 06:06:56
Documents
3
Effectiveness Date
2016-11-08

Document Format Files

Seq Description Document Type Size
1 DEFA14A d284118ddefa14a.htm DEFA14A 21715
2 GRAPHIC g284118g18u22.jpg GRAPHIC 43967
3 GRAPHIC g284118g61v53.jpg GRAPHIC 26724
  Complete submission text file 0001193125-16-762290.txt   120384
Mailing Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080 650-635-7000
MATEON THERAPEUTICS INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-21990 | Film No.: 161979878
SIC: 2836 Biological Products, (No Diagnostic Substances)